1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Central Nervous System (CNS) Biomarkers Market
2.2. Global Central Nervous System (CNS) Biomarkers Market, By Type, 2023 (US$ Million)
2.3. Global Central Nervous System (CNS) Biomarkers Market, By Application, 2023 (US$ Million)
2.4. Global Central Nervous System (CNS) Biomarkers Market, By End User, 2023 (US$ Million)
2.5. Global Central Nervous System (CNS) Biomarkers Market, By Geography, 2023 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2023

3. Central Nervous System (CNS) Biomarkers Market: Competitive Analysis
3.1. Market Positioning of Key Central Nervous System (CNS) Biomarkers Market Vendors
3.2. Strategies Adopted by Central Nervous System (CNS) Biomarkers Market Vendors
3.3. Key Industry Strategies
4. Central Nervous System (CNS) Biomarkers Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Central Nervous System (CNS) Biomarkers Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Central Nervous System (CNS) Biomarkers Market: By Type, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Safety Biomarkers
5.3.2. Efficacy Biomarkers
5.3.3. Validation Biomarkers
5.3.4. Others

6. Central Nervous System (CNS) Biomarkers Market: By Application, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Drug Discovery and Development
6.3.2. Personalized Medicine
6.3.3. Others

7. Central Nervous System (CNS) Biomarkers Market: By End User, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Market Segmentation
7.3.1. Diagnostic Labs
7.3.2. Clinics/Hospitals
7.3.3. Research Centers


8. North America Central Nervous System (CNS) Biomarkers Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Central Nervous System (CNS) Biomarkers Market: By Type, 2022-2032, USD (Million)
8.3. Central Nervous System (CNS) Biomarkers Market: By Application, 2022-2032, USD (Million)
8.4. Central Nervous System (CNS) Biomarkers Market: By End User, 2022-2032, USD (Million)
8.5.Central Nervous System (CNS) Biomarkers Market: By Region, 2022-2032, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Central Nervous System (CNS) Biomarkers Market: By Type, 2022-2032, USD (Million)
8.5.1.1.2. Central Nervous System (CNS) Biomarkers Market: By Application, 2022-2032, USD (Million)
8.5.1.1.3. Central Nervous System (CNS) Biomarkers Market: By End User, 2022-2032, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Central Nervous System (CNS) Biomarkers Market: By Type, 2022-2032, USD (Million)
8.5.1.2.2. Central Nervous System (CNS) Biomarkers Market: By Application, 2022-2032, USD (Million)
8.5.1.2.3. Central Nervous System (CNS) Biomarkers Market: By End User, 2022-2032, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Central Nervous System (CNS) Biomarkers Market: By Type, 2022-2032, USD (Million)
8.5.1.3.2. Central Nervous System (CNS) Biomarkers Market: By Application, 2022-2032, USD (Million)
8.5.1.3.3. Central Nervous System (CNS) Biomarkers Market: By End User, 2022-2032, USD (Million)

9. UK and European Union Central Nervous System (CNS) Biomarkers Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Central Nervous System (CNS) Biomarkers Market: By Type, 2022-2032, USD (Million)
9.3. Central Nervous System (CNS) Biomarkers Market: By Application, 2022-2032, USD (Million)
9.4. Central Nervous System (CNS) Biomarkers Market: By End User, 2022-2032, USD (Million)
9.5.Central Nervous System (CNS) Biomarkers Market: By Region, 2022-2032, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Central Nervous System (CNS) Biomarkers Market: By Type, 2022-2032, USD (Million)
9.5.1.1.2. Central Nervous System (CNS) Biomarkers Market: By Application, 2022-2032, USD (Million)
9.5.1.1.3. Central Nervous System (CNS) Biomarkers Market: By End User, 2022-2032, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Central Nervous System (CNS) Biomarkers Market: By Type, 2022-2032, USD (Million)
9.5.1.2.2. Central Nervous System (CNS) Biomarkers Market: By Application, 2022-2032, USD (Million)
9.5.1.2.3. Central Nervous System (CNS) Biomarkers Market: By End User, 2022-2032, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Central Nervous System (CNS) Biomarkers Market: By Type, 2022-2032, USD (Million)
9.5.1.3.2. Central Nervous System (CNS) Biomarkers Market: By Application, 2022-2032, USD (Million)
9.5.1.3.3. Central Nervous System (CNS) Biomarkers Market: By End User, 2022-2032, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Central Nervous System (CNS) Biomarkers Market: By Type, 2022-2032, USD (Million)
9.5.1.4.2. Central Nervous System (CNS) Biomarkers Market: By Application, 2022-2032, USD (Million)
9.5.1.4.3. Central Nervous System (CNS) Biomarkers Market: By End User, 2022-2032, USD (Million)
9.5.1.5. France
9.5.1.5.1. Central Nervous System (CNS) Biomarkers Market: By Type, 2022-2032, USD (Million)
9.5.1.5.2. Central Nervous System (CNS) Biomarkers Market: By Application, 2022-2032, USD (Million)
9.5.1.5.3. Central Nervous System (CNS) Biomarkers Market: By End User, 2022-2032, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Central Nervous System (CNS) Biomarkers Market: By Type, 2022-2032, USD (Million)
9.5.1.6.2. Central Nervous System (CNS) Biomarkers Market: By Application, 2022-2032, USD (Million)
9.5.1.6.3. Central Nervous System (CNS) Biomarkers Market: By End User, 2022-2032, USD (Million)

10. Asia Pacific Central Nervous System (CNS) Biomarkers Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Central Nervous System (CNS) Biomarkers Market: By Type, 2022-2032, USD (Million)
10.3. Central Nervous System (CNS) Biomarkers Market: By Application, 2022-2032, USD (Million)
10.4. Central Nervous System (CNS) Biomarkers Market: By End User, 2022-2032, USD (Million)
10.5.Central Nervous System (CNS) Biomarkers Market: By Region, 2022-2032, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Central Nervous System (CNS) Biomarkers Market: By Type, 2022-2032, USD (Million)
10.5.1.1.2. Central Nervous System (CNS) Biomarkers Market: By Application, 2022-2032, USD (Million)
10.5.1.1.3. Central Nervous System (CNS) Biomarkers Market: By End User, 2022-2032, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Central Nervous System (CNS) Biomarkers Market: By Type, 2022-2032, USD (Million)
10.5.1.2.2. Central Nervous System (CNS) Biomarkers Market: By Application, 2022-2032, USD (Million)
10.5.1.2.3. Central Nervous System (CNS) Biomarkers Market: By End User, 2022-2032, USD (Million)
10.5.1.3. India
10.5.1.3.1. Central Nervous System (CNS) Biomarkers Market: By Type, 2022-2032, USD (Million)
10.5.1.3.2. Central Nervous System (CNS) Biomarkers Market: By Application, 2022-2032, USD (Million)
10.5.1.3.3. Central Nervous System (CNS) Biomarkers Market: By End User, 2022-2032, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Central Nervous System (CNS) Biomarkers Market: By Type, 2022-2032, USD (Million)
10.5.1.4.2. Central Nervous System (CNS) Biomarkers Market: By Application, 2022-2032, USD (Million)
10.5.1.4.3. Central Nervous System (CNS) Biomarkers Market: By End User, 2022-2032, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Central Nervous System (CNS) Biomarkers Market: By Type, 2022-2032, USD (Million)
10.5.1.5.2. Central Nervous System (CNS) Biomarkers Market: By Application, 2022-2032, USD (Million)
10.5.1.5.3. Central Nervous System (CNS) Biomarkers Market: By End User, 2022-2032, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Central Nervous System (CNS) Biomarkers Market: By Type, 2022-2032, USD (Million)
10.5.1.6.2. Central Nervous System (CNS) Biomarkers Market: By Application, 2022-2032, USD (Million)
10.5.1.6.3. Central Nervous System (CNS) Biomarkers Market: By End User, 2022-2032, USD (Million)

11. Latin America Central Nervous System (CNS) Biomarkers Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Central Nervous System (CNS) Biomarkers Market: By Type, 2022-2032, USD (Million)
11.3. Central Nervous System (CNS) Biomarkers Market: By Application, 2022-2032, USD (Million)
11.4. Central Nervous System (CNS) Biomarkers Market: By End User, 2022-2032, USD (Million)
11.5.Central Nervous System (CNS) Biomarkers Market: By Region, 2022-2032, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Central Nervous System (CNS) Biomarkers Market: By Type, 2022-2032, USD (Million)
11.5.1.1.2. Central Nervous System (CNS) Biomarkers Market: By Application, 2022-2032, USD (Million)
11.5.1.1.3. Central Nervous System (CNS) Biomarkers Market: By End User, 2022-2032, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Central Nervous System (CNS) Biomarkers Market: By Type, 2022-2032, USD (Million)
11.5.1.2.2. Central Nervous System (CNS) Biomarkers Market: By Application, 2022-2032, USD (Million)
11.5.1.2.3. Central Nervous System (CNS) Biomarkers Market: By End User, 2022-2032, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Central Nervous System (CNS) Biomarkers Market: By Type, 2022-2032, USD (Million)
11.5.1.3.2. Central Nervous System (CNS) Biomarkers Market: By Application, 2022-2032, USD (Million)
11.5.1.3.3. Central Nervous System (CNS) Biomarkers Market: By End User, 2022-2032, USD (Million)

12. Middle East and Africa Central Nervous System (CNS) Biomarkers Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Central Nervous System (CNS) Biomarkers Market: By Type, 2022-2032, USD (Million)
12.3. Central Nervous System (CNS) Biomarkers Market: By Application, 2022-2032, USD (Million)
12.4. Central Nervous System (CNS) Biomarkers Market: By End User, 2022-2032, USD (Million)
12.5.Central Nervous System (CNS) Biomarkers Market: By Region, 2022-2032, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Central Nervous System (CNS) Biomarkers Market: By Type, 2022-2032, USD (Million)
12.5.1.1.2. Central Nervous System (CNS) Biomarkers Market: By Application, 2022-2032, USD (Million)
12.5.1.1.3. Central Nervous System (CNS) Biomarkers Market: By End User, 2022-2032, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Central Nervous System (CNS) Biomarkers Market: By Type, 2022-2032, USD (Million)
12.5.1.2.2. Central Nervous System (CNS) Biomarkers Market: By Application, 2022-2032, USD (Million)
12.5.1.2.3. Central Nervous System (CNS) Biomarkers Market: By End User, 2022-2032, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Central Nervous System (CNS) Biomarkers Market: By Type, 2022-2032, USD (Million)
12.5.1.3.2. Central Nervous System (CNS) Biomarkers Market: By Application, 2022-2032, USD (Million)
12.5.1.3.3. Central Nervous System (CNS) Biomarkers Market: By End User, 2022-2032, USD (Million)

13. Company Profile
13.1. Thermo Fisher Scientific
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Portfolio
13.1.4. Strategic Initiatives
13.2. F. Hoffmann-La Roche
13.2.1. Company Overview
13.2.2. Financial Performance
13.2.3. Product Portfolio
13.2.4. Strategic Initiatives
13.3. Bio-Rad Laboratories
13.3.1. Company Overview
13.3.2. Financial Performance
13.3.3. Product Portfolio
13.3.4. Strategic Initiatives
13.4. QIAGEN
13.4.1. Company Overview
13.4.2. Financial Performance
13.4.3. Product Portfolio
13.4.4. Strategic Initiatives
13.5. Siemens Healthineers
13.5.1. Company Overview
13.5.2. Financial Performance
13.5.3. Product Portfolio
13.5.4. Strategic Initiatives
13.6. Myriad Genetics
13.6.1. Company Overview
13.6.2. Financial Performance
13.6.3. Product Portfolio
13.6.4. Strategic Initiatives
13.7. Johnson & Johnson
13.7.1. Company Overview
13.7.2. Financial Performance
13.7.3. Product Portfolio
13.7.4. Strategic Initiatives
13.8. Avid Radiopharmaceuticals
13.8.1. Company Overview
13.8.2. Financial Performance
13.8.3. Product Portfolio
13.8.4. Strategic Initiatives
13.9. Merck KGaA
13.9.1. Company Overview
13.9.2. Financial Performance
13.9.3. Product Portfolio
13.9.4. Strategic Initiatives
13.10. Quanterix Corporation
13.10.1. Company Overview
13.10.2. Financial Performance
13.10.3. Product Portfolio
13.10.4. Strategic Initiatives
13.11. Other Notable Players
13.11.1. Company Overview
13.11.2. Financial Performance
13.11.3. Product Portfolio
13.11.4. Strategic Initiatives